The Rao lab is focused on glioma, the most common and deadliest primary brain tumor in humans. A fundamental interest of the lab is understanding the process of malignant progression of glioma. Many ...

The analysts also noted that the company had initiated a $2 billion share buyback "despite this negative dynamic." — CNBC's Ganesh Rao contibuted to this story.

O n December 21, consul general of Japan in Kolkata, Nakagawa Koichi presented a Certificate of Conferment to Choppla Ganesh Rao, in recognising his great contribution for 35 years to the official ...